Keywords
How to Cite
Abstract
In this study, various therapeutic strategies are examined for the treatment of Tourette Syndrome, with an emphasis on pharmacological and non-pharmacological approaches. Initially, we highlight the effectiveness of recent pharmacological interventions developed, emphasizing their ability to control symptoms of the disease and improve patients' quality of life. These emerging therapies are not limited to symptom relief but also aim to address the underlying causes of the condition, considering the complex interaction between neurobiological and environmental factors.
In addition to pharmacological interventions, innovative non-pharmacological approaches are being explored, such as behavioral therapies and lifestyle modulation. These strategies include cognitive-behavioral therapies, social skills training, and relaxation techniques, which have been shown to be effective in reducing tics and managing stress. Ongoing research in this field is crucial to identify the most effective approaches and adapt them to individual patient needs.
Furthermore, it is important to highlight the role of specific medications in the treatment of Tourette Syndrome, including antipsychotics, dopaminergic agonists, and adjuvant agents. These medications aim to control motor and vocal tics as well as the behavioral symptoms associated with the condition, providing relief to patients affected by the Syndrome.
In summary, the approach to treatment is increasingly focused on the combination of pharmacological and non-pharmacological therapy. The integration of these therapeutic strategies can offer a more comprehensive and personalized approach to managing the condition, significantly improving the quality of life of patients. However, further research is needed to fully understand the underlying mechanisms and optimize the use of these therapeutic interventions in clinical practice.
References
Andrén, P., et al. (2022). European clinical guidelines for Tourette syndrome and other tic disorders—version 2.0. Part II: psychological interventions. European Child & Adolescent Psychiatry, 31(3), 403–423.
Dyke, K., Jackson, G., & Jackson, S. (2022). Non‑invasive brain stimulation as therapy: systematic review and recommendations with a focus on the treatment of Tourette syndrome. Experimental Brain Research, 240(2), 341–363.
Frey, J., & Malaty, I. A. (2022). Tourette Syndrome Treatment Updates: a Review and Discussion of the Current and Upcoming Literature. Current Neurology and Neuroscience Reports, 22, 123–142.
Grados, et al. (2021). Mechanisms Underlying Behavior Therapy for Tourette’s Disorder. Current Developmental Disorders Reports, 8, 161–174.
Kleimaker, M. et al. (2020). Non-invasive Brain Stimulation for the Treatment of Gilles de la Tourette Syndrome. Frontiers in Neurology, 11, 592258.
McGuire et al. (2022). Cognitive Control Processes in Behavior Therapy for Youth with Tourette’s Disorder. Journal of Child Psychology and Psychiatry, 63(3), 296–304.
Nomura, Y. (2022). Pharmacological therapy for Tourette syndrome: What medicine can do and cannot do. Biomedical Journal, 45(2), 229-239.
Quezada, J., & Coffman, K. A. (2018). Current Approaches and New Developments in the Pharmacological Management of Tourette Syndrome. CNS Drugs, 32, 33–45.
Rizwan et al. (2022). Efficacy of Behavioral Intervention, Antipsychotics, and Alpha Agonists in the Treatment of Tics Disorder in Tourette’s Syndrome. Cureus, 14(2), e22449.
Wang et al. (2024). Efficacy and safety of combined deep brain stimulation with capsulotomy for comorbid motor and psychiatric symptoms in Tourette’s syndrome: Experience and evidence. Asian Journal of Psychiatry, 94, 103960.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2024 Ana Laura Zanett Alvarenga, Caio Aloísio de Oliveira Cardoso , Caio Cesar Queiroz Nogueira, Arthur Henrique dos Santos Vieira, Stefânia Ungaro Lanfredi